Expertise in
3
conditions

Timothy P. Hughes

North Terrace, 
Adelaide, SA, AU 
Expertise in
3
conditions
North Terrace, 
Adelaide, SA, AU 

Overview

Timothy Hughes practices practicing medicine in Adelaide, Australia.

Mr. Hughes is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Leukemia, Acute Lymphoblastic Leukemia (ALL), Pleural Effusion, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 208 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

North Terrace, Adelaide, SA 5000, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Enrollment Status: Completed
Publish Date: March 17, 2026
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 2
A Multicenter, Single Arm Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP) Who Are Intolerant to Prior Tyrosine Kinase Inhibitors (TKIs).
A Multicenter, Single Arm Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukemia in Chronic Phase (Ph+ CML-CP) Who Are Intolerant to Prior Tyrosine Kinase Inhibitors (TKIs).
Enrollment Status: Terminated
Publish Date: October 27, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

208 Total Publications

From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia.
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia.
Journal: Leukemia
Published: May 01, 2026

Frequently Asked Questions about Timothy P. Hughes

Is Timothy P. Hughes a top-rated expert for Chronic Myelogenous Leukemia (CML)?

MediFind is an objective health platform that identifies experts based on real-world data. Timothy P. Hughes is classified as an Elite expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Timothy P. Hughes participate in research or clinical trials?

Yes. Timothy P. Hughes has published 208 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Timothy P. Hughes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hughes's expertise for a condition
ConditionClose
View All 7 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile